CCL23 and acute myeloid leukemia: Previously known as myeloid progenitor inhibitor factor (MPIF)-1 and CKβ8 [28,34], CCL23’s increased expression in AML cells is associated with a tendency towards poorer prognosis (p = 0.059) according to data from UALCAN (https://ualcan.path.uab.edu accessed 21 June 2023) [23,24], suggesting clinical relevance for AML patients.